Intellia Therapeutics Stock Forecast

Sell candidate since Oct 27, 2025 Loss -42.66%

The Intellia Therapeutics Inc stock price fell by -2.53% on the last day (Monday, 17th Nov 2025) from $8.70 to $8.48. During the last trading day the stock fluctuated 6.99% from a day low at $8.23 to a day high of $8.81. The price has fallen in 6 of the last 10 days and is down by -35.12% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -688 thousand shares and in total, 6 million shares were bought and sold for approximately $51.34 million.

Given the current short-term trend, the stock is expected to rise 17.33% during the next 3 months and, with a 90% probability hold a price between $9.95 and $34.42 at the end of this 3-month period.

NTLA Signals & Forecast

There are few to no technical positive signals at the moment. The Intellia Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.25 and $17.97. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, October 20, 2025, and so far it has fallen -69.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Intellia Therapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.575 between high and low, or 6.99%. For the last week, the stock has had daily average volatility of 9.18%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NTLA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Intellia Therapeutics Inc to open at $8.51, and during the day (based on 14 day Average True Range), to move between $7.63 and $9.33, which gives a possible trading interval of +/-$1.69 (+/-22.17%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 22.17% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $8.67, some $0.190 (2.24%) from the current price of $8.48, our system finds the risk reward not very attractive.

Is Intellia Therapeutics Inc stock A Buy?

The Intellia Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Intellia Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.011 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $8.51 ( 0.295%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk